FDA Grants Pfizer, BioNTech Emergency Use Authorization for COVID-19 Vaccine

The companies plan in the coming week to begin distributing the first vials of BNT162b2, a two-dose vaccine that is indicated for the prevention of COVID-19 in individuals 16 years of age and older.

The post FDA Grants Pfizer, BioNTech Emergency Use Authorization for COVID-19 Vaccine appeared first on GEN – Genetic Engineering and Biotechnology News.

Published on Sat, 12 Dec 2020 03:38:45 +0000 and delivered to you by power automate translate text